Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-12

Clinical Trial Update: Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing intradermal microinjections of tranexamic acid versus oral tranexamic acid for melasma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral tranexamic acid (tranexamic acid)
  • Tanexamic Acid (tranexamic acid)

Snippet

Sponsor: Hayat Abad Medical Complex, Peshawar | Conditions: Melasma | EARLY_Phase 1 | Status: COMPLETED